Coniferaldehyde Reverses PGK1–3-Phosphoglycerate–L-Serine Metabolic Reprogramming in Hindlimb Ischemia
4 affiliations
- 1Department of Anesthesiology, Ninghai First Hospital, Ningbo 315600, China
- 2Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
- 3The First Clinical Medical College, Wenzhou Medical University, Wenzhou 325000, China
- 4Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin 300052, China
Abstract
Background/Objectives: Ischemic skeletal muscle undergoes metabolic remodeling that may influence vascular repair. We investigated whether coniferaldehyde (CA) regulates a phosphoglycerate kinase 1 (PGK1)–3-phosphoglycerate (3PG)–L-serine axis in mouse hindlimb ischemia (HLI). Methods: Gastrocnemius tissue from Sham, HLI, and HLI+CA mice (n = 6/group) underwent bulk RNA sequencing and untargeted metabolomics. Public single-cell data and hypoxic human skeletal muscle cells (HSkMCs) were used to examine PGK1. AlphaFold3 modeling, molecular dynamics simulation, and a cellular thermal shift assay (CETSA) were used to evaluate a potential CA–PGK1 interaction. HSkMC-conditioned media were applied to human umbilical vein endothelial cells (HUVECs), with 3PG supplementation where indicated. Results: Amino-acid biosynthesis and glycine/serine/threonine metabolism were enriched in HLI muscle. 3PG increased in HLI versus Sham (p = 0.0170) and decreased in HLI+CA versus HLI (p = 0.0358); L-serine followed the same pattern (p = 0.0274 and p = 0.0428, respectively). Pgk1 expression also increased in HLI versus Sham (p = 0.00348) and decreased in HLI+CA versus HLI (p = 0.00249). Hypoxia increased HSkMC PGK1 together with extracellular 3PG and serine, whereas CA attenuated all three. Modeling predicted a stable CA–PGK1 complex, and CETSA supported a potential CA–PGK1 interaction in cell lysates. Conditioned medium from CA-treated hypoxic HSkMCs improved HUVEC viability, redox, tube-formation, and wound-closure readouts, reduced reactive oxygen species, and increased glutathione peroxidase 4 (GPX4) and solute carrier, family 7 member 11 (SLC7A11); 3PG supplementation reversed these effects. Conclusions: CA modulates a PGK1-linked 3PG/L-serine metabolic axis, while 3PG exposure altered endothelial phenotypes in the conditioned-medium model.
Related
- An LRH-1 agonist reverses hepatic metabolic dysfunction in obesity
- Targeting SLC6A14-mediated nutrient competition reverses an immunosuppressive metabolic niche in pancreatic cancer.
- Targeting Metabolic Reprogramming in Cancer: Past, Present, and Future
- HER3 mediates metabolic reprogramming in metastatic colorectal and pancreatic cancer
- Temporal Single-Nucleus Transcriptomics Defines PPARα/CPT1A-Associated Metabolic Reprogramming During Proximal Tubular Injury and Repair
BibTeX
@article{dong2026coniferaldehyde,
title = {{Coniferaldehyde Reverses PGK1–3-Phosphoglycerate–L-Serine Metabolic Reprogramming in Hindlimb Ischemia}},
author = {Yun Dong and Chunbo Ma and Xueli Wang and Jiaping Han and Zina Zhu and Suwen Hu and Zixuan Hu and Liangrong Wang},
journal = {Metabolites},
year = {2026},
month = oct,
doi = {10.3390/metabo16100756},
url = {https://www.mdpi.com/2218-1989/16/10/756},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Coniferaldehyde Reverses PGK1–3-Phosphoglycerate–L-Serine Metabolic Reprogramming in Hindlimb Ischemia
AU - Yun Dong
AU - Chunbo Ma
AU - Xueli Wang
AU - Jiaping Han
AU - Zina Zhu
AU - Suwen Hu
AU - Zixuan Hu
AU - Liangrong Wang
PY - 2026
DA - 2026/10/09
JO - Metabolites
DO - 10.3390/metabo16100756
UR - https://www.mdpi.com/2218-1989/16/10/756
AB - Background/Objectives: Ischemic skeletal muscle undergoes metabolic remodeling that may influence vascular repair. We investigated whether coniferaldehyde (CA) regulates a phosphoglycerate kinase 1 (PGK1)–3-phosphoglycerate (3PG)–L-serine axis in mouse hindlimb ischemia (HLI). Methods: Gastrocnemius tissue from Sham, HLI, and HLI+CA mice (n = 6/group) underwent bulk RNA sequencing and untargeted metabolomics. Public single-cell data and hypoxic human skeletal muscle cells (HSkMCs) were used to examine PGK1. AlphaFold3 modeling, molecular dynamics simulation, and a cellular thermal shift assay (CETSA) were used to evaluate a potential CA–PGK1 interaction. HSkMC-conditioned media were applied to human umbilical vein endothelial cells (HUVECs), with 3PG supplementation where indicated. Results: Amino-acid biosynthesis and glycine/serine/threonine metabolism were enriched in HLI muscle. 3PG increased in HLI versus Sham (p = 0.0170) and decreased in HLI+CA versus HLI (p = 0.0358); L-serine followed the same pattern (p = 0.0274 and p = 0.0428, respectively). Pgk1 expression also increased in HLI versus Sham (p = 0.00348) and decreased in HLI+CA versus HLI (p = 0.00249). Hypoxia increased HSkMC PGK1 together with extracellular 3PG and serine, whereas CA attenuated all three. Modeling predicted a stable CA–PGK1 complex, and CETSA supported a potential CA–PGK1 interaction in cell lysates. Conditioned medium from CA-treated hypoxic HSkMCs improved HUVEC viability, redox, tube-formation, and wound-closure readouts, reduced reactive oxygen species, and increased glutathione peroxidase 4 (GPX4) and solute carrier, family 7 member 11 (SLC7A11); 3PG supplementation reversed these effects. Conclusions: CA modulates a PGK1-linked 3PG/L-serine metabolic axis, while 3PG exposure altered endothelial phenotypes in the conditioned-medium model.
SN - 2218-1989
ER -